Concepedia

Mark W. Drummond

MW

Statistics

Publications

34

Citations

2.6K

H-Index

21

Active since

1993

Affiliations

Beatson West of Scotland Cancer Centre(Current)

Guy's and St Thomas' NHS Foundation Trust

The University of Texas MD Anderson Cancer Center

Princess Margaret Cancer Centre

University of Oxford

Mark W. Drummond is an author at Beatson West of Scotland Cancer Centre specializing in medicine, pharmacology, and hematology.

Publications per year

1993–2023

34

Publications

34

Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis

Animesh Pardanani, Claire Harrison, Jörge E. Cortes et al. · JAMA Oncology · 2015 · 472 citations

, , +14

Pacritinib vs Best Available Therapy, Including Ruxolitinib, in Patients With Myelofibrosis

John Mascarenhas, Ronald Hoffman, Moshe Talpaz et al. · JAMA Oncology · 2018 · 380 citations · Full text

, , +13

Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia

Michael Andreeff, Kevin R. Kelly, Karen Yee et al. · Clinical Cancer Research · 2015 · 353 citations

, , +17

Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial

Daniel J. DeAngelo, Deepti Radia, Tracy I. George et al. · Nature Medicine · 2021 · 150 citations · Full text

, , +14

Single-cell multi-omics identifies chronic inflammation as a driver of TP53-mutant leukemic evolution

Alba Rodríguez-Meira, Ruggiero Norfo, Sean Wen et al. · Nature Genetics · 2023 · 144 citations · Full text

, , +17

1–5 of 34